arrow
J

J. Pedro Teixeira

university of new mexico
H指数:14
被引数:985

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Proceedings of the University of Alabama at Birmingham Continuous Renal Replacement Therapy Academy (2023-2024)

阿拉巴马大学伯明翰分校连续肾脏替代疗法学院会议录(2023-2024)

2025-10-011
PRE
Acute skeletal muscle wasting in patients with acute kidney injury requiring continuous kidney replacement therapy: A prospective multicenter study

急性肾损伤需要连续肾脏替代治疗患者的急性骨骼肌萎缩:一项前瞻性多中心研究

2025-06-120
PRE
Shock prediction with dipeptidyl peptidase-3 and renin (SPiDeR) in hypoxemic patients with COVID-19

二肽基peptidase-3和肾素 (SPiDeR) 在新型冠状病毒肺炎低氧血症患者中的休克预测

2025-02-010
PRE
Acute Kidney Injury in Patients With Cirrhosis and Chronic Kidney Disease: Results From the HRS-HARMONY Consortium

肝硬化合并慢性肾脏病患者中的急性肾损伤:HRS-HARMONY联盟的研究结果

2024-12-130
PRE
Association of Hepatorenal Syndrome-Acute Kidney Injury with Mortality in Patients with Cirrhosis Requiring Renal Replacement Therapy

肝肾综合征-急性肾损伤与需要肾脏替代治疗的肝硬化患者死亡率的关系

2024-09-301
OAAI
Efficacy and Safety of Remdesivir in People With Impaired Kidney Function Hospitalized for Coronavirus Disease 2019 Pneumonia: A Randomized Clinical Trial

Remdesivir对因冠状病毒疾病住院的肾功能受损患者的疗效和安全性2019肺炎: 一项随机临床试验

2024-06-244
OAAI
Disproportionate impact of COVID-19 severity and mortality on hospitalized American Indian/Alaska Native patients

新型冠状病毒肺炎严重程度和死亡率对住院的美洲印第安人/阿拉斯加原住民患者的影响不成比例

2023-08-294
OAAI
Ramipril for the Treatment of COVID-19: RAMIC, a Randomized, Double-Blind, Placebo-Controlled Clinical Trial
2023-08-242
OA